Abstract:Topic: 28. Enzymopathies, membranopathies and other anemias Background: Pseudouridine (Ψ) is the most abundant RNA modification in cells. Growing evidences suggest that pseudouridine is critical in physiology and pathology processes. The importance of this biological function is exemplified by the clinical syndrome called mitochondrial myopathy, lactic acidosis and sideroblastic anemia syndrome (MLASA), in which genetic mutations of pseudouridine synthase 1 (PUS1) cause defective pseudouridylation that leads to MLASA. However, the roles of pseudouridylation in normal erythropoiesis and in anemia of MLASA remain poorly understood. Aims: To explore the role and the molecular mechanism underlying pseudouridine modification in erythropoiesis dysfunction and anemia. Methods: We established a mouse model carrying a point mutation R110W located in enzymatic domain of PUS1 with CRISPR-Cas9, mimicking the same mutation site mostly seen in human MLASA patients. Phenotypic studies such as the peripheral blood routine, erythroid development of bone marrow and spleen, the proportion and absolute number of cells in each stage of hematopoiesis were analyzed. Serial competitive transplantation experiments were performed to identify the ability of hematopoietic stem and progenitor cells in regeneration of erythroid cells. Furthermore, the oxidative phosphorylation of erythroid cells was measured by Seahorse experiment, and the activities mitochondrial OXPHOS complex units was determined by ELISA. The mitochondrial membrane potential, mitochondrial mass, mitochondrial superoxide and cellular Ros levels of erythroid cells were also determined by flow cytometry. In order to study the effect of R110W mutation on tRNA and translation, tRNA PCR Array were used to determine the changes of tRNA expression in mutant mouse erythroid cells, and RNA sequencing and Ribosome profiling were done to characterize the differentially translated proteins in mutant mouse erythroid cells. To clarify the effects of mitochondrial OXPHOS, cytoplasmic translation and mitochondrial translation on erythroid development, and the corresponding inhibitors were evaluated in an in vitro erythroid differentiation system. Results:Pus1 mutant mice (R110W) exhibited anemia at 4-week of age due to a blockage of erythroid maturation in both bone marrow and spleen. Whereas MEP is slightly decreased in R110W groups, the HSPC population is mainly unchanged in steady state when compared with that of the controls. During serial transplantation, the recovery of erythroid and platelet in R110W groups was continuously decreased. While lymphoid reconstitution is maintained during the first transplantation, a large decrease was observed in the secondary transplantation, indicating an cell autonomous deficiency in R110W HSCs function under transplantation stress. In consistent with mitochondrial dysfunction observed in MLASA patients, impaired mitochondrial OXPHOS, altered activity of OXPHOS complex I and III, and elevated oxidative stress were also observed in R110W BM erythroblasts. Mechanistically, BM erythroblasts of PUS1 R110W mutant mice showed defective pseudouridylation of targeted tRNAs and altered mitochondrial and cytoplasmic tRNA profiles as revealed by tRNA PCR Array and CMCT assay. Consequently, R110W erythroblasts exhibited decreased cytoplasmic translation, suppressed translation efficiency of ribosomal protein genes, and a lower level of hemoglobin protein, which led to ineffective erythropoiesis. Summary/Conclusion: Our study thus provided direct evidences that pseudouridylation participates in erythropoiesis in vivo, and demonstrated a critical role of pseudouridylation in regulating tRNA homeostasis, ribosome biogenesis, and erythropoiesis.Keywords: Erythropoieisis, Anemia

Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis

Biochemical Characterization of the Mitochondrial Trnaser(ucn) T7511C Mutation Associated with Nonsyndromic Deafness

Mutation in Trmu Related to Transfer Rna Modification Modulates the Phenotypic Expression of the Deafness-Associated Mitochondrial 12s Ribosomal Rna Mutations

Pseudouridine Synthase 1 Regulates Erythropoiesis Via Transfer RNAs Pseudouridylation and Cytoplasmic Translation

Mitochondrial tRNA pseudouridylation governs erythropoiesis

S275: PUS1 REGULATES ERYTHROPOIESIS VIA TRNA PSEUDOURIDYLATION AND CYTOPLASMIC TRANSLATION

Hearing impairment-associated KARS mutations lead to defects in aminoacylation of both cytoplasmic and mitochondrial tRNA Lys

Decoding Pseudouridine: an Emerging Target for Therapeutic Development.

Nonsense Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells with SF3B1 and U2AF1 Mutations

Loss of Pseudouridine Synthases in the RluA Family Causes Hypersensitive Nociception in Drosophila

Pseudouridinylation of mRNA coding sequences alters translation

Exploring pseudouridylation: dysregulation in disease and therapeutic potential

Mutations in the U2 snRNA gene RNU2-2P cause a severe neurodevelopmental disorder with prominent epilepsy

Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.

Renal Hypouricemia Caused by Novel Compound Heterozygous Mutations in the SLC22A12 Gene: a Case Report with Literature Review.

Mutations in the U2 snRNA gene cause a severe neurodevelopmental disorder with prominent epilepsy

The molecular basis of tRNA selectivity by human pseudouridine synthase 3

Mutations in Multiple Components of the Nuclear Pore Complex Cause Nephrotic Syndrome

Combined tRNA modification defects impair protein homeostasis and synthesis of the yeast prion protein Rnq1

Defects in t6A tRNA modification due to GON7 and YRDC mutations lead to Galloway-Mowat syndrome

Mutations in the non-coding RNU4ATAC gene affect the homeostasis and function of the Integrator complex